tirzepatide eli lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Lilly's Weight-Loss Drug Approved in

Call or text (925) 817-8186 or book online today.

Kathryn Kline, MD, Texas Medical Board License T3117 Standard Texas Telehealth Medical Disclaimer Medical Disclaimer: The information provided in this article is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment

Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Real Ro patients shared their experiences before and after Zepbound

In clinical trials, it has shown effectiveness in reducing hemoglobin A1c levels, promoting insulin sensitivity, and assisting with weight loss